Connect with us

Health

Research team identifies potential drug to treat SARS-CoV-2 – Medical Xpress

A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by…

Published

on

Article feature image

A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch (UTMB).
The medication bepridil, which goes by the trade name Vascor, is currently approved by the U.S. Food and Drug Administration (FDA) to treat angina, a heart condition.
The team’s leaders are College of Science professor Wenshe Ray Liu, professor and…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Covid-19 variants pose ‘real threat’ to vaccine progress, CDC warns – Yahoo News Australia
Article feature image
Studies reveal the promise of newly engineered bispecific antibodies against tumor cells – News-Medical.Net